Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, Committee S-TS, and Investigators
It undergoes enzymatic processing from its preproglucagon peptide precursor within intestinal L-cells, ultimately giving rise to GLP-1(1-37) and peptide variants including GLP-1(7-36)
That means they can be sold legally, but they have not been through the same safety and efficacy assessment as licensed medicines
Mar 5 2024;465:133412
However, the absence of any signal across large-scale studies and the current pharmacovigilance data provides reasonable confidence that tirzepatide does not directly cause erectile dysfunction through its pharmacological mechanism
Genetic Predispositions and Personalized Treatment Selection Emerging evidence suggests genetic variation in GLP-1 receptor pathways, FTO, and MC4R genes may influence individual response to GLP-1 medications